Sen. Elizabeth Warren speaking at an event
Sen. Elizabeth Warren (D-Mass.) was one of the organizers of a congressional Democratic letter to PhRMA inquiring about "rapid price hikes affecting the vast majority of popular brand name drugs.”

Congressional Democrats Confront PhRMA About Brand Drug Price Hikes

Thirteen congressional Democrats—eight senators and five representatives—asked Pharmaceutical Research and Manufacturers of America (PhRMA) to respond by March 8 to questions about “rapid price hikes affecting the vast majority of popular brand name drugs.”

Sens. Elizabeth Warren (Mass.) and Amy Klobuchar (Minn.) and Reps. Katie Porter (Calif.) and Jan Schakowsky (Ill.) organized the March 1 letter to PhRMA President and CEO Stephen Ubl. Sens. Tammy Baldwin (Wis.), Maggie Hassan (N.H.), Bernard Sanders (I-Vt.), Tina Smith (Minn.), Sheldon Whitehouse (R.I.), and Ron Wyden (Ore.) and Reps. Peter DeFazio (Ore.), Peter Welch (Vt.), and Susan Wild (Pa.) signed it.

Thirteen congressional Democrats—eight senators and five representatives—asked Pharmaceutical Research and Manufacturers of America (PhRMA) to respond by March 8 to questions about “rapid price hikes affecting the vast majority of popular brand name drugs.”

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

×

*Sign up for news summaries and alerts from 340B Report

Site Footer